Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform
Clinical trial NCT05916755 · RECRUITING
Trial details
- NCT number
- NCT05916755
- Sponsor
- Vall d'Hebron Institute of Oncology
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-13
- Primary completion
- 2026-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.